AMINOLOGICS CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,442 KRW | -0.48% |
|
-0.41% | +7.29% |
| 2023 | Aminologics Co.,Ltd.(KOSDAQ:A074430) dropped from S&P Global BMI Index | CI |
| 2023 | Aminologics Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
| Sales 2022 | 27.34B 19.85M | Sales 2023 | 20.89B 15.16M | Capitalization | 118B 85.7M |
|---|---|---|---|---|---|
| Net income 2022 | -7.28B -5.29M | Net income 2023 | 2.44B 1.77M | EV / Sales 2022 | 4.88 x |
| Net cash position 2022 | 27.25B 19.78M | Net cash position 2023 | 26.68B 19.37M | EV / Sales 2023 | 4.37 x |
| P/E ratio 2022 |
-22.1
x | P/E ratio 2023 |
48.5
x | Employees | 38 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 68.46% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.48% | ||
| 1 week | -0.41% | ||
| 1 month | -4.06% | ||
| 3 months | -12.34% | ||
| 6 months | +7.77% | ||
| Current year | +7.29% |
1 week
1 401.00
1 460.00
1 month
1 401.001 541.00
Current year
1 350.001 950.00
1 year
1 125.001 950.00
3 years
1 125.003 600.00
5 years
1 040.004 355.00
10 years
986.004 450.00
| Managers | Title | Age | Since |
|---|---|---|---|
Seong-Seok Oh
CEO | Chief Executive Officer | 69 | - |
Jang-Seok Oh
CEO | Chief Executive Officer | 71 | 14-03-26 |
Seung-Ye Oh
BRD | Director/Board Member | 39 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jang-Seok Oh
CEO | Chief Executive Officer | 71 | 14-03-26 |
Seong-Seok Oh
CEO | Chief Executive Officer | 69 | - |
Joo-Hyeong Oh
BRD | Director/Board Member | 42 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-31 | 1,442 | -0.48% | 86,503 |
| 24-05-30 | 1,449 | +0.35% | 120,784 |
| 24-05-29 | 1,444 | +0.77% | 89,545 |
| 24-05-28 | 1,433 | +0.42% | 79,090 |
| 24-05-27 | 1,427 | -1.45% | 354,047 |
End-of-day quote Korea S.E., May 30, 2024
More quotes
Aminologics Co.,Ltd. is a Korea-based company mainly engaged in the manufacture and distribution of image processing chips for digital video recorders (DVRs). The Company operates its business through in two divisions: information technology (IT) division and amino acid division. Its IT division engages in the manufacture of DVR system-on-chips (SoCs), analog and digital integrated chips, multiplexer and display chips, color quad chips, video codec, peripheral component interconnect (PCI) one chips and others. Its amino acid division produces unnatural amino acids, which are used for pharmaceutical development. On July 29, 2013, the Company sold its entire shares of U-CHANG PLANT CONSTRUCTION CO., LTD. On December 23, 2013, Sam-Oh Pharm Co Ltd became the largest shareholder of the Company by acquiring a 16.67% stake in the Company.
Sector
Pharmaceuticals
Calendar
2024-08-12
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +7.29% | 91.58M | |
| +40.73% | 739B | |
| +31.13% | 598B | |
| -6.30% | 353B | |
| +15.15% | 318B | |
| +4.05% | 285B | |
| +15.02% | 240B | |
| +9.49% | 210B | |
| -5.15% | 206B | |
| +6.17% | 164B |
- Stock Market
- Equities
- A074430 Stock
